WHO puts Ebola outbreak death rate at ‘huge’ 30-50% as chief arrives in DRC

WHO Chief Warns of High Ebola Mortality as Outbreak Escalates in DRC

WHO puts Ebola outbreak death rate - The World Health Organization (WHO) has raised alarm over the mortality rate of the Ebola outbreak in the Democratic Republic of the Congo (DRC), stating it could reach as high as 30% to 50%. This figure, shared by Anaïs Legand of the WHO’s high threat pathogens team, highlights the severity of the crisis, which has seen 10 confirmed deaths and 223 suspected cases since its declaration on 15 May. Legand emphasized that the revised estimate reflects confirmed cases, underscoring the gravity of the situation with a stark warning: “It’s huge. It means that up to five out of 10 people are likely to die.”

First Confirmed Recovery Offers Hope

Despite the grim outlook, a small glimmer of optimism emerged as a patient in the DRC was discharged from a health center on 27 May after two negative tests. This marks the first verified recovery in the current outbreak, a critical milestone for medical teams working to combat the disease. The WHO’s data reveals that over 1,000 individuals have been affected, with the outbreak’s true extent potentially larger due to undetected transmission in the region.

Tedros Adhanom Ghebreyesus, the WHO’s director general, arrived in Kinshasa on Thursday, signaling a heightened global focus on the crisis. His visit coincided with the announcement of a delayed trip to the outbreak’s epicenter in the mineral-rich Ituri province, pushing the schedule back by one day. During a press briefing, Tedros asserted, “That thing can be stopped,” and urged unity, stating, “Together, we will overcome this outbreak.” He also promised to “do everything in my power to help,” emphasizing the organization’s commitment to containing the epidemic.

Conflict and Displacement Complicate Response

The outbreak’s location in a volatile region has added layers of complexity to containment efforts. Armed groups, including the Rwanda-backed M23, control large parts of the North and South Kivu provinces, where the virus has been spreading. Tedros highlighted how “conflict and displacement make everything harder,” urging warring factions to declare a ceasefire. “No cause, no conflict, no grievance is worth condemning innocent people to death from a preventable disease,” he said, framing the crisis as a moral imperative for regional peace.

Since January 2025, over 245,000 people have fled eastern DRC to neighboring countries, according to the UN refugee agency. This mass displacement has created challenges for health officials, who must navigate both logistical hurdles and the ongoing instability. The DRC’s 17th recorded Ebola epidemic, the outbreak has persisted for over a year, with the disease first identified in the country in 1976. Historically, the mortality rate has averaged around 50% across all outbreaks, but the current strain, Bundibugyo, presents unique challenges.

Regional Responses and Border Measures

Uganda, which reported one confirmed death and eight additional cases, took immediate action by closing its border with the DRC on Wednesday. The WHO cautioned that such closures might increase informal crossings, complicating efforts to track and control the virus. In Kenya, the high court temporarily halted plans to create a quarantine facility for affected U.S. citizens, citing constitutional concerns. The Katiba Institute, a Kenyan rights group, argued the proposal “raises grave constitutional concerns regarding the rights to life, health, fair administrative action, public participation, and parliamentary oversight.”

Kenya’s decision to suspend the plan was criticized by health officials, who warned it could strain the nation’s already overburdened healthcare system. The country’s main medical union threatened strike action unless the terms of the U.S.-Kenya agreement were made public within 48 hours. U.S. officials had announced the 50-bed facility at an air force base would be operational on Friday, but the legal challenge has delayed its implementation.

Global Efforts and Vaccine Development

As the WHO and international partners race to contain the outbreak, the organization has called for expanded clinical trials of vaccines and treatments. While no approved therapy exists for the Bundibugyo strain, advisory groups have recommended testing new options to accelerate progress. Jean Kaseya, head of the African Union’s health agency, expressed confidence that a vaccine could be ready by the end of the year, offering a potential breakthrough in the fight against the virus.

Early signs of Ebola include fever, exhaustion, muscle pain, headaches, and sore throat, which can progress to vomiting, diarrhea, abdominal pain, rashes, and organ dysfunction. The virus spreads through direct contact with bodily fluids or blood of infected individuals, making containment difficult in densely populated areas. With over 1,000 cases reported and the outbreak’s true scale possibly underestimated, the WHO’s latest assessments underscore the urgency of the situation.

Backed by scientific data, the WHO’s revised mortality figures have sparked debates about the effectiveness of current containment strategies. While Tedros dismissed the need for travel bans, citing their limited impact, the DRC’s geographical challenges and political tensions remain significant barriers. The region’s remote locations and limited infrastructure have slowed response efforts, yet the WHO’s presence and international collaboration provide a lifeline for affected communities.

Broader Implications and Future Outlook

The DRC’s Ebola outbreak has drawn attention to the country’s fragile healthcare systems and the role of regional conflicts in exacerbating public health crises. With a population exceeding 100 million, the DRC’s ability to manage the outbreak depends on coordinated efforts between local authorities, the WHO, and international partners. The first confirmed recovery, though small, signals that progress is possible, but widespread success will require sustained resources and community engagement.

As the situation evolves, the WHO and other organizations face the dual challenge of addressing immediate health needs while preparing for long-term solutions. The development of a vaccine, projected to be ready by year’s end, could be a game-changer, but its distribution and acceptance in the region will be crucial. Meanwhile, the DRC’s experience with Ebola serves as a reminder of the virus’s potential to disrupt entire communities, especially in areas where displacement and conflict are commonplace.

International Collaboration and Challenges

Global solidarity has been a key factor in managing the outbreak, yet disparities in response efforts persist. While Uganda’s closure of its border aims to prevent further spread, the WHO warns that such measures may not be sufficient and could even encourage risky behavior. In Kenya, the court’s intervention highlights tensions between public health mandates and individual rights, raising questions about how to balance safety with humanitarian concerns.

The U.S. Public Health Service, with over 30 staff deployed to the DRC, has played a pivotal role in supporting containment efforts. Their work, however, is not without challenges, as they must operate in an environment marked by both natural and human-made obstacles. The WHO’s ongoing assessments, combined with scientific advancements in vaccine research, offer hope that the outbreak can be brought under control, though time remains a critical factor in preventing a larger epidemic.

With the DRC’s Ebola crisis reaching new heights, the world watches closely for developments. The 30-50% mortality rate, confirmed by the WHO, highlights the urgency of the situation, but it also galvanizes international efforts to provide aid and innovation. Whether these measures will be enough to turn the tide remains uncertain, but the commitment of global health leaders and the resilience of affected communities provide a foundation for hope.